Assistant Professor of Medicine, Massachusetts General Hospital

Oncology

Beverly Moy, MD works in the field of Oncology. She graduated from Albert Einstein College of Medicine of Yeshiva University. She over the years received 1 awards: "Meaningful Use Stage 1 Certification". Beverly has written publications. She has 26 publications published with PubMed. The lastest paper is: 'Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled,...' She accepts all Medicare patients.

Publications

---

• Identification of early breast Cancer patient cohorts who may benefit from lapatinib therapy.
• Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
• Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
• Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.
• Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HE...
• Variation in type of adjuvant chemotherapy received among patients with stage I breast Cancer: A multi-institutional study.
• Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast Cancer.
• Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience.
• Debating the Oncologist's Role in Defining the Value of Cancer Care: Our Duty Is to Our Patients.
• American Society of Clinical Oncology Policy Statement on Medicaid Reform.
• Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical On...
• Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study.
• Massachusetts general hospital: improving patient access to the Breast oncology clinic.
• A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast Cancer brain metastases.
• Correlation between financial relationships with commercial interests and research prominence at an oncology meeting.
• The Cost of Cancer Care--Balancing Our Duties to Patients Versus Society: Are They Mutually Exclusive?
• Adjuvant lapatinib for women with early-stage HER2-positive breast Cancer: a randomised, controlled, phase 3 trial.
• Patient Navigation for Underserved Patients Diagnosed with Breast Cancer.
• Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced o...
• Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormo...
• Circulating tumor cells as predictors of response and failure in breast Cancer patients treated with preoperative chemotherapy.
• Value of Cancer care: ethical considerations for the practicing oncologist.
• Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast C...
• Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast Cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled,...
• Trends in the use of mastectomy in women with small node-negative breast Cancer treated at US academic centers.

Schools

---

• Albert Einstein College of Medicine of Yeshiva University

• Brigham and Women39s Hospital

• Beth Israel Deaconess Med Center

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Anemia
• Antiphospholipid Syndrome (APS)
• Bile Duct Cancer
• Bladder Cancer
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification

Education

---

• Brigham and Women's Hospital
• Albert Einstein College of Medicine of Yeshiva University

Hospital

---

• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1932199106
NPPES Provider LastName		MOY
NPPES Provider FirstName		BEVERLY
NPPES Provider ZIPCode		021142606
NPPES Provider State		MA
Specialty Description		Hematology/Oncology
Total Claim Count		188.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1932199106
Last Name Of The Provider	MOY
First Name Of The Provider	BEVERLY
View All

Similar Doctors

---

	Dr. Steven L. McAfee, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Daniel E. Morganstern, MD This Doctor is OpenDoctor Recommended.
	Dr. Rania M. Seliem, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason E. Faris, MD This Doctor is OpenDoctor Recommended.
	Dr. K G. VanAsse, MD This Doctor is OpenDoctor Recommended.
	Dr. Suniti N. Nimbkar, MD This Doctor is OpenDoctor Recommended.
	Dr. Adam F. Binder, MD This Doctor is OpenDoctor Recommended.
	Dr. Mandar D. Muzumdar, MD This Doctor is OpenDoctor Recommended.
	Dr. David M. Jackman, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Atish D. Choudhury, MD This Doctor is OpenDoctor Recommended.
	Dr. Pankaj Bhargava, MD This Doctor is OpenDoctor Recommended.
	Dr. Kerry L. Massman, MD This Doctor is OpenDoctor Recommended.
	Dr. Leonard L. Ellman, MD This Doctor is OpenDoctor Recommended.
	Dr. Edwin Choy, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christopher J. Sweeney, MD
	Dr. Jill N. Allen, MD
	Dr. Jennifer A. Chan, MD
	Dr. Andrew J. Yee, MD This Doctor is OpenDoctor Recommended.
	Dr. Noopur S. Raje, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Adam Lerner, MD This Doctor is OpenDoctor Recommended.
	Dr. Anumeha Gupta, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog